Highlights Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
3.1 ^USD	-2.52%		+6.53%	+87.88%

12/04	Transcript : Generation Bio Co. - Special Call
07/03	Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03	CI
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/03	CI
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Generation Bio Co. Announces Demonstration of Highly Selective T Cell Transduction in Vivo with Cell-Targeted Lnp Platform	26/23/26	CI
Generation Bio Co. Announces Breakthrough in Its Non-Viral Genetic Medicine Platform with Novel "Immune-Quiet" Dna	18/23/18	CI
Generation Bio Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	03/23/03	CI
Generation Bio Co. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI
Moderna, Generation Bio Working Together to Develop Non-Viral Genetic Medicines	23/23/23	MT
Moderna, Inc. and Generation Bio Co. Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines	23/23/23	CI
GENERATION BIO CO. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	24/23/24	AQ
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	24/23/24	CI
Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
GENERATION BIO CO. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/22/04	AQ
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04/22/04	CI
GENERATION BIO CO. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	05/22/05	AQ
Generation Bio Co. Reports Earnings Results for the Second Quarter Ended June 30, 2022	05/22/05	CI
Generation Bio Co. Announces Update to its Good Manufacturing Process Manufacturing Strategy	21/22/21	CI
GENERATION BIO CO. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	06/22/06	AQ
Generation Bio Co. Reports Earnings Results for the First Quarter Ended March 31, 2022	06/22/06	CI
GENERATION BIO CO. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	25/22/25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Generation Bio Co.

Equities

GBIO

US37148K1007

Highlights

Filters